In the same period, our study revealed seven participants among 340 (2.05%) who seroconverted to anti-CHIKV IgG, while in a blood panel collected during a dengue outbreak, 22 samples among 497 (4.42%) had anti-CHIKV IgM. The gene discussed is CD40LG; the disease is dengue disease.